Dhruva K Mishra1, Kenneth L Scott2, Joanna M Wardwell-Ozgo2, Michael J Thrall3, Min P Kim4. 1. Department of Surgery, Houston Methodist Research Institute, Houston, Texas. 2. Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas. 3. Department of Pathology and Genomic Medicine, Houston Methodist Research Institute, Houston, Texas. 4. Department of Surgery, Houston Methodist Research Institute, Houston, Texas; Department of Surgery, Weill Cornell Medical College, Houston Methodist Hospital, Houston, Texas. Electronic address: mpkim@houstonmethodist.org.
Abstract
BACKGROUND: Currently, there is no in vitro or ex vivo model that can isolate circulating tumor cells (CTCs). Recently, we developed a four-dimensional (4D) lung cancer model that allows for the isolation of CTCs. We postulated that these cells have different properties than parental (2D) cells. MATERIALS AND METHODS: We obtained CTCs by growing A549, H1299, 393P, and 344SQ cell lines on the 4D lung model. The CTCs were functionally characterized in vitro and gene expression of the cell adhesion molecules was compared with respective 2D cells. Integrin beta 4 (ITGB4) was further investigated by stably transfecting the A549 and H1299 cells. RESULTS: We found that all cell lines produced CTCs, and that CTCs from the 4D model were less adherent to the plastic and have a slower growth rate than respective 2D cells (P < 0.01). Most of the cell adhesion molecules were downregulated (P < 0.05) in CTCs, and ITGB4 was the common molecule, significantly more underexpressed in CTCs from all cell lines than their respective 2D cells. The modulation of ITGB4 led to a differential function of 2D cells. CONCLUSIONS: CTCs from the 4D model have different transcriptional, translational, and in vitro characteristics than the same cells grown on a petri dish, and these CTCs from the 4D model have the properties of CTCs that are responsible for metastasis.
BACKGROUND: Currently, there is no in vitro or ex vivo model that can isolate circulating tumor cells (CTCs). Recently, we developed a four-dimensional (4D) lung cancer model that allows for the isolation of CTCs. We postulated that these cells have different properties than parental (2D) cells. MATERIALS AND METHODS: We obtained CTCs by growing A549, H1299, 393P, and 344SQ cell lines on the 4D lung model. The CTCs were functionally characterized in vitro and gene expression of the cell adhesion molecules was compared with respective 2D cells. Integrin beta 4 (ITGB4) was further investigated by stably transfecting the A549 and H1299 cells. RESULTS: We found that all cell lines produced CTCs, and that CTCs from the 4D model were less adherent to the plastic and have a slower growth rate than respective 2D cells (P < 0.01). Most of the cell adhesion molecules were downregulated (P < 0.05) in CTCs, and ITGB4 was the common molecule, significantly more underexpressed in CTCs from all cell lines than their respective 2D cells. The modulation of ITGB4 led to a differential function of 2D cells. CONCLUSIONS: CTCs from the 4D model have different transcriptional, translational, and in vitro characteristics than the same cells grown on a petri dish, and these CTCs from the 4D model have the properties of CTCs that are responsible for metastasis.
Authors: Harald C Ott; Ben Clippinger; Claudius Conrad; Christian Schuetz; Irina Pomerantseva; Laertis Ikonomou; Darrell Kotton; Joseph P Vacanti Journal: Nat Med Date: 2010-07-13 Impact factor: 53.440
Authors: Dhruva K Mishra; Michael J Thrall; Brandi N Baird; Harald C Ott; Shanda H Blackmon; Jonathan M Kurie; Min P Kim Journal: Ann Thorac Surg Date: 2012-03-02 Impact factor: 4.330
Authors: Edward W Howard; Steve C L Leung; H F Yuen; Chee Wai Chua; Davy T Lee; K W Chan; Xianghong Wang; Yong Chuan Wong Journal: Clin Exp Metastasis Date: 2008-03-14 Impact factor: 5.150
Authors: Steven J Cohen; Cornelis J A Punt; Nicholas Iannotti; Bruce H Saidman; Kert D Sabbath; Nashat Y Gabrail; Joel Picus; Michael Morse; Edith Mitchell; M Craig Miller; Gerald V Doyle; Henk Tissing; Leon W M M Terstappen; Neal J Meropol Journal: J Clin Oncol Date: 2008-07-01 Impact factor: 44.544
Authors: Dhruva K Mishra; Chad J Creighton; Yiqun Zhang; Don L Gibbons; Jonathan M Kurie; Min P Kim Journal: Int J Cancer Date: 2013-09-03 Impact factor: 7.396
Authors: Kevin G Phillips; Anand Kolatkar; Kathleen J Rees; Rachel Rigg; Dena Marrinucci; Madelyn Luttgen; Kelly Bethel; Peter Kuhn; Owen J T McCarty Journal: Front Oncol Date: 2012-08-09 Impact factor: 6.244
Authors: Don L Gibbons; Wei Lin; Chad J Creighton; Shuling Zheng; Dror Berel; Yanan Yang; Maria Gabriela Raso; Diane D Liu; Ignacio I Wistuba; Guillermina Lozano; Jonathan M Kurie Journal: PLoS One Date: 2009-04-30 Impact factor: 3.240
Authors: Eva Rademaker; Esther Bastiaannet; Jan Oosting; Neeltje G Dekker-Ensink; Peter J K Kuppen; Noel F C C de Miranda; Gerrit J Liefers Journal: J Gastrointest Cancer Date: 2022-02-03
Authors: Salah-Eddine Lamhamedi-Cherradi; Sana Mohiuddin; Dhruva K Mishra; Min P Kim; Joseph A Ludwig; Sandhya Krishnan; Alejandra Ruiz Velasco; Amelia M Vetter; Kristi Pence; David McCall; Danh D Truong; Branko Cuglievan; Brian A Menegaz; Budi Utama; Najat C Daw; Eric R Molina; Rafal J Zielinski; John A Livingston; Richard Gorlick; Antonios G Mikos Journal: Cancer Gene Ther Date: 2021-01-06 Impact factor: 5.987